title: Are recommendations for the routine use of pharmacological thromboprophylaxis in total hip arthroplasty justified?
authors.affiliation: Joint Replacement Institute, Los Angeles, California 90007, USA.
authors.forename: H C
authors.initials: HC
authors.lastname: Amstutz
authors.forename: F J
authors.initials: FJ
authors.lastname: Dorey
mesh_terms: D019644:Arthroplasty, Replacement, Hip; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000401:mortality / Q000517:prevention & control*; D011292:Premedication; D015996:Survival Rate; D013923:Thromboembolism / Q000401:mortality / Q000517:prevention & control*; D015912:Thrombolytic Therapy
chemical_list: D005343:Fibrinolytic Agents